9
1 Microwave-Accelerated Palladium- Catalyzed Organic and Medicinal Chemistry Mats Larhed Division of Organic Pharmaceutical Chemistry Department of Medicinal Chemistry Uppsala University Sweden [email protected] Microwave UGM November 7, 2007 Copenhagen Disposition Introduction Carbonylations Oxidative Heck reactions – Pd(II) Heck reactions – Pd(0) HIV-1 protease inhibitors Acknowledgement 2007 - the Carl von Linnaeus Tercentenary An Improved in situ Amino-Carbonylation Protocol with Mo(CO) 6 as a solid CO Source Cr(CO) 6 80% Mo(CO) 6 84% W(CO) 6 77% Fe 3 (CO) 12 0% Co 2 (CO) 8 28% DBU mediated CO release Improved method with sluggish amines and amino acids ArCl work with [(t- Bu) 3 PH]BF 4 and Herrmann’s pallada- cycle Wu et al. Organometallics 2006, 1434 Lagerlund et al. J. Comb. Chem. 2006, 4 Wu et al. Org. Lett 2005, 3327 Wannberg et al. J. Org. Chem. 2003, 5751 Wan et al. J. Comb. Chem. 2003, 82 Wan et al. J. Org. Chem. 2002, 6232 Kaiser et al. J. Comb. Chem. 2002, 109 FAB-MS M(CO) 6 Yield X Mo O O O O O O HNR'R'' Mo N N O O O O N N O NR'R'' 2 CO [Pd], Mo(CO)6 Air, 15 min DBU, THF + 10 equiv DBU + R R X = I, Br, Cl 39 examples 35-95% Aminocarbonylation or Heck Reaction with Allylamine? No competing Heck reaction R I NH2 Mo(CO)6, Pd(OAc)2 DBU, Dioxane MW, 125 o C, 10 min R N H O R Br NH2 R N H O P Pd o-tol o-tol OAc [(t-Bu)3PH]BF4, Mo(CO)6 DBU, Dioxane dimer MW 140 o C, 15 min R Cl NH2 R N H O P Pd o-tol o-tol OAc [(t-Bu)3PH]BF4, Mo(CO)6 DBU, Dioxane dimer MW 160 o C, 20 min 66-81% 8 Examples 66-80% 10 Examples 55-78% 8 Examples Appukuttan et al. Submitted Me N H O N H O N H O H N O MeO N H O N H O NH2 O S H N N H O O O HN O NH N H O H N O OMe OMe N H O H N O O HN NH O O O H N O S H N O2N N N H O NH2 N H O NHMe Scale-Up of Aminocarbonylation 0.4 mMol scale in 3 mL dioxane (81%) 2.0 mMol scale in 10 mL dioxane (78%) 25.0 mMol scale in 125 mL dioxane (80%) Direct scalability No problem with Mo(CO) 6 , 4 bars pressure I MeO N H O MeO H 2 N Mo(CO) 6 , Pd(OAc) 2 DBU, Dioxane MW, 125 o C, 10 min Appukuttan et al. Submitted Aminocarbonylations of Aryl Triflates in Neat Water Under development Mo(CO) 6 as a solid CO-source X-Phos needed Only small amounts of benzoic acid generated Odell et al. In preparation OTf H N R2 R1 R H2N OTf OTf X-Phos, Na2CO3 OTf R HN N R1 R2 O Mo(CO)6, Palladacycle H2O, MW, 175 o C, 40 min Yield 36-72 % +

Microwave-Accelerated Palladium- Disposition...1 Microwave-Accelerated Palladium-Catalyzed Organic and Medicinal Chemistry Mats Larhed Division of Organic Pharmaceutical Chemistry

  • Upload
    others

  • View
    14

  • Download
    1

Embed Size (px)

Citation preview

Page 1: Microwave-Accelerated Palladium- Disposition...1 Microwave-Accelerated Palladium-Catalyzed Organic and Medicinal Chemistry Mats Larhed Division of Organic Pharmaceutical Chemistry

1

Microwave-Accelerated Palladium-Catalyzed Organic and Medicinal Chemistry

Mats LarhedDivision of Organic Pharmaceutical Chemistry

Department of Medicinal ChemistryUppsala University Sweden

[email protected]

Microwave UGMNovember 7, 2007

Copenhagen

Disposition

• Introduction• Carbonylations• Oxidative Heck reactions – Pd(II)• Heck reactions – Pd(0)• HIV-1 protease inhibitors• Acknowledgement

2007 - the Carl von Linnaeus Tercentenary

An Improved in situ Amino-Carbonylation Protocol with Mo(CO) 6 as a solid CO Source

• Cr(CO)6 80%• Mo(CO)6 84%• W(CO)6 77%• Fe3(CO)12 0%• Co2(CO)8 28%

• DBU mediated CO release

• Improved method with sluggish amines and amino acids

• ArCl work with [( t-Bu)3PH]BF 4 and Herrmann’s pallada-cycle

Wu et al. Organometallics 2006, 1434Lagerlund et al. J. Comb. Chem. 2006, 4Wu et al. Org. Lett 2005, 3327Wannberg et al. J. Org. Chem. 2003, 5751Wan et al. J. Comb. Chem. 2003, 82Wan et al. J. Org. Chem. 2002, 6232Kaiser et al. J. Comb. Chem. 2002, 109

FAB-MS

M(CO)6 Yield

X

Mo

O

O

OO

O

O

HNR'R''

Mo

N

N

OO

O

O

N

N

O

NR'R''

2 CO

[Pd], Mo( CO)6

Air, 15 minDBU, THF

+

10 equiv DBU+

R RX = I, Br, Cl39 examples35-95%

Aminocarbonylation or Heck Reaction with Allylamine?

• No competing Heck reaction

R

I NH2

Mo(CO)6, Pd(OAc) 2

DBU, DioxaneMW, 125 oC, 10 min

R

NH

O

R

Br

NH2R

NH

OPPd

o-tolo-tol

OAc

[(t-Bu)3PH]BF4, Mo(CO)6

DBU, Dioxane

dimer

MW 140 oC, 15 min

R

Cl

NH2R

NH

OPPd

o-tolo-tol

OAc

[(t-Bu)3PH]BF4, Mo(CO)6

DBU, Dioxane

dimer

MW 160 oC, 20 min

66-81%8 Examples

66-80%10 Examples

55-78%8 Examples

Appukuttan et al. Submitted

Me

NH

O

NH

O

NH

O

HN

O

MeO

NH

O

NH

O

NH2

OS

HN

NH

O

O

O

HNO

NH NH

O

HN

O

OMe

OMe

NH

O

HN

O

O

HNNH

O

OO

HN

OS

HN

O2N

N

NH

O

NH2

NH

O

NHMe

Scale-Up of Aminocarbonylation

• 0.4 mMol scale in 3 mL dioxane (81%)• 2.0 mMol scale in 10 mL dioxane (78%)• 25.0 mMol scale in 125 mL dioxane (80%)• Direct scalability• No problem with Mo(CO) 6, 4 bars pressure

I

MeO

NH

O

MeO

H2N

Mo(CO)6, Pd(OAc) 2

DBU, Dioxane

MW, 125 oC, 10 min

Appukuttan et al. Submitted

Aminocarbonylations of Aryl Triflates in Neat Water

• Under development• Mo(CO)6 as a solid CO-source• X-Phos needed• Only small amounts of benzoic acid generated

Odell et al. In preparation

OTfH N

R2

R1

R

H2NOTfOTf

X-Phos, Na 2CO3

OTf

R

HN

NR1

R2

O

Mo(CO)6, Palladacycle

H2O, MW, 175 oC, 40 minYield 36-72 %

+

Page 2: Microwave-Accelerated Palladium- Disposition...1 Microwave-Accelerated Palladium-Catalyzed Organic and Medicinal Chemistry Mats Larhed Division of Organic Pharmaceutical Chemistry

2

Hepatitis C Virus (HCV)

• 170 million infected

• 3-4 million newly infected/year

• Primary indication for liver transplantations

• Urgent need for better therapies

Sandström et al.

Development of Novel Peptidomimetic HCV Protease Inhibitors

Other substituents

N

O

O

HN

ONH

N

O

O

O

HN

O

SO

O

Ki = 0.025 nMEC50 = 0.93 nM

Ongoing Lampa, ÅkerblomCyclization (metathesis)

NH

O

O

Unnatural amino acid

Örtqvist et al. Bioorg. Med. Chem. 2007, 15, 1448-1474

Ongoing

variation of the acyl sulfonamide function!

Rönn et al. Bioorg. Med. Chem. 2006, 14, 544-559

Rönn et al. Submitted

aromatic backbone

Rönn et al. Submitted

To be continued

heterocyclic backbone

Ongoing Örtqvist, Gising

ββββ-amino acidsOngoing Nurbo

Sandström et al.

Synthesis of Acyl Sulfonamides with Mo(CO) 6

O

NH

OS

O O

O

IH2N

SO O

INH

OS

O O

INH

OS

O O

I

Ph

O

NH

OS

O O

F3C

I

F3C

NH

OS

O O

S I NH

OS

O O

S

S

I

NH

OS

O O

S

H2NS

O O

NH

OS

O O

H2NS

O O

Br

NH

OS

O O

Br

H2NS

O ONH

OS

O O

H2NS

O O

CF3

NH

OS

O O

CF3

NH

OS

O OI

NH

OS

O O

Ph

O

Entry Iodide Sulfon amide Pr oduct Isolated yield (%)

188

87

88

80

70

76

88

65

79

88

84

72

71

2

3

4

5

6

7

8

9

10

11

12

13

I

HNS

O O14 N

OS

O O

47

NH

OS

O OBr

H2NS

O O

Br

F

F

F

F3C

NH

OS

O O

BrNH

OS

O O

S Br NH

OS

O O

S

NH

OS

O OBr

NC

NH

OS

O O

NC

Br

H2NS

O O

H2NS

CF3

O O

NH

OS

O O

NH

OS

CF3

O O

Entry Bromide S ulfonamide Product Isolated yield (%)

1

2

3

4

5

6

7

8

9

10

11

O

Br

O

NH

OS

O O

Br

O

NH

OS

O O

O

Br

NH

OS

O O

93

94

91

93

95

96

95

83

79

88

80

ArX

H2NS

R

O O

NH

SR

O O

Ar

O

+microwaves15 min

[Pd], Mo(CO) 6

DBU, dioxane

Wu et al. J. Org. Chem. 2005, 3094

Synthesis of a Hepatitis C Virus NS3 Protease Inhibitor

O

NH

BocHN SO O

Br

N

O

N

O

O

OH

OBocHN

NH

O

SO

O

N

O

N

O

O

HN

OBocHN

ONH

SO

O

O

NH

BocHN SO O

HN

OS

O O

1. HCl/1,4-dioxane

2. HBTU, DIEA, DMF

[Pd], Mo(CO) 6

DBU, dioxane

microwaves 15 min

H2NS

O O

K i-value of 85 ± 7 nM

52%

76%

Wu et al. J. Org. Chem.2005, 3094

HCV Full-length NS3(protease-helicase/NTPase)

H2N BrN

OBocHN

O

N

O

O

NH

N

OBocHN

O

N

O

O

NH

R1

R2

Br

Br

H2NBr

R1

R2

N

OBocHN

O

N

O

O

NH

N

OBocHN

O

N

O

O

HN

ONH

R1

R2

SOO

O

NH

S RO O

Microwaves140 oC, 15 min

RSO2NH2Herrmann's palladacycle

Fu salt, Mo(CO) 6, DBU1,4-dioxane

ortho (77%)meta (63%)para (82%)

ortho, R=phenyl (35%), 830 nMmeta, R=phenyl (44%)para, R=phenyl (35%)ortho, R=methyl (50%), 5900 nMortho, R=cyclopropyl (62%)ortho, R=benzyl (56%)ortho, R=4-methoxyphenyl (43%)ortho, R=4-(trifluoromethyl)phenyl (42%), 310 nMortho, R=2-thienyl (37%)

R1=CH3, R2=H (76%)R1=H, R2=CF3 (88%)

R1=CH3, R2=H (45%), 3200 nMR1=H, R2=CF3 (35%), 310 nM

HATU, DIEACH2Cl2, 45 oC

POCl3, pyridine-15 oC to rt

Microwaves140 oC, 15 min

PhSO2NH2Herrmann's palladacycle

Fu salt, Mo(CO) 6, DBU1,4-dioxane

N

OBocHN

O

N

O

O

OH

Novel HCV Protease Inhibitors by Amidocarbonylation

Rönn et al. Submitted

Preparative Advances and Lessons Learned

• Mo(CO)6 serves as a reliable solid CO liberator both with classic heating and microwave heating

• Inter- and intramolecular Pd(0)-catalyzed amino-, am ido-, hydrazido- and alkoxycarbonylations proceed smoothly in organic solvents, fluorous solvents or water

• Aryl iodides, -bromides, -chlorides and –triflates are all good substrates

• The methodology is useful for lead optimization• Limitation: The reaction mixture must be directly s ealed

after addition of Mo(CO) 6 and efficiently stirred

NH

HN

OH

OH

O

O

O

O

I

I

O

OSi

Si

NH

HN

OH

OH

O

O

O

OO

OSi

Si

NH2

O

H2N

O66%

Mo(CO)6, [(t-Bu) 3PH]BF 4Palladacycle, DIEA, DBUNH2OH x HCl , Dioxane

MW, 120 oC, 20 min

M. Larhed: Microwave-promoted carbonylations. Modern Carbonylation Methods , L. Kollár, Ed. Wiley-VCH, In Print

Page 3: Microwave-Accelerated Palladium- Disposition...1 Microwave-Accelerated Palladium-Catalyzed Organic and Medicinal Chemistry Mats Larhed Division of Organic Pharmaceutical Chemistry

3

The Oxidative Heck Reaction

R Ar B(OH)2[Pd(II)] R

Ar

+ + Pd(0)

Reoxidation

R Ar X[Pd(0)] R

Ar

+

The Oxidative Heck Reaction:

The Heck Reaction:

Richard F. Heck

Heck

Pd(0) Pd(II)

Pd(0)

R1

B(R2)2

OxidativeHeck

Ar1 X

Ar1

R1

Ar2

R1

Suzuki

Ar1 Ar2

Ar2

Oxidative Heck Reactions

• Boronic acids readily undergo trans-metallation

• Which reoxidant to use?

• Very few mechanistic studies

• Microwave scale-up?

Relation between the classic Heck reaction, the oxidative Heck reaction and the Suzuki coupling

Andappan et al. Mol. Div. 2003, 97, Enquist et al. J. Org. Chem. 2006, 8779, Andappan et al. J. Org. Chem. 2004, 5212, Enquist et al. Green Chemistry 2006, 338.

H3C

B(OH)2

N

OPd(OAc) 2, dmphen

N

O+NaOAc, MeCN, air, rt

Reaction Investigated with ESI-MS

• Electron-rich olefin• NaOAc as base• Samples for ESI-MS removed during reaction

Enquist et al. J. Org. Chem. 2006, 8779

N N

2,9-dimethyl-1,10-phenanthroline (dmphen)

The palladium acetate catalyzed dmphen-modulated ox idative Heck reaction in acetonitrile with an electron-rich olefin. Cationic intermediates in the catalytic cycle are assigned letters from A–C.

The Plausible Catalytic Cycle of the Oxidative Heck Reaction

N

O N

O

NN

N

NPdN

PdNN

NN

PdOAc

N N

N

O

N

N

C

PdN

N

N

PdOAc

N

N

N

PdN

HN

H2O2

O2 (Air)

A

B

(HO)2B

N N

+

+

=

2,9-dimethyl-1,10-phenanthroline (dmphen)

Base-Free Oxidative Heck

PdN

N NH• Homocoupling intermediate detected by ESI-MS

• Produced from the p-Tolyl-Pd intermediate and p-Tolyl boronic acid

• Small amount biaryl side-product observed in all Oxidative Heck reactions

• Base needed for Suzuki-type biaryl formation• Base screen showed no need for base in Oxidative

Heck• Jung reported the base-free Oxidative Heck during

our studies (Jung et al. J. Am. Chem. Soc. 2006, 16384) with O 2 as oxidant

• Can we perform this chemistry with air instead of O 2?• Improved chemoselectivity? Microwaves?

Base-Free Oxidative Heck

• Reactions at room temperature: Open vessel charged with boronic acid, n-butyl acrylate, Pd(OAc) 2 (0.02 equiv), dmphen(0.024 equiv) and acetonitrileunder vigorous stirring

• Reactions at elevated temperatures: Microwave-transparent vessel charged with boronic acid, n-butyl acrylate, p-benzoquinone (0.5 equiv), Pd(OAc) 2 (0.02 equiv), dmphen(0.024 equiv), acetonitrile, sealed under air and exposed to microwave irradiation

• Scale-up at room temp from 1 mmol to 50 mmol scale

n-Bu

B(OH)2

n-Bu

CO2Bu

B(OH)2O

O

CO2BuO

O

B(OH)2HOCO2Bu

HO

B(OH)2 CO2Bu

Ac

B(OH)2

Ac

CO2Bu

B(OH)2

O

CO2Bu

O

F3C

B(OH)2

F3C

CO2Bu

MeO

B(OH)2

MeO

CO2Bu

B(OH)2 CO2Bu

1 rt100

24 h10 min

8486

2 rt100

18 h10 min

4968

3rt100rt

18 h10 min18 h

979497

4 rt100

24 h10 min

8385

5 rt100

48 h10 min

9050

6 rt100

24 h10 min

9389

7 rt100

72 h10 min

9290

8 rt100

48 h10 min

9577

9 rt100

48 h10 min

7095

CO2Bu ArB(OH) 2

Pd(OAc) 2 ArCO2Budmphen

+

_______________________________________________________________entry boronic acid product T (°C) t yield (%)_______________________________________________________________

Lindh et al. J. Org. Chem. 2007, 7957

Page 4: Microwave-Accelerated Palladium- Disposition...1 Microwave-Accelerated Palladium-Catalyzed Organic and Medicinal Chemistry Mats Larhed Division of Organic Pharmaceutical Chemistry

4

Base-Free Oxidative

Heck rt100

rt120

24 h1 h

9874

N

O

rt100

O

rt100

CO2Bu rt100

rt100

rt100

Ac

CO2Bu

CO2Bu

N

O

Ac

N

O

O

Ac

O

CO2Bu

Ac

CO2Bu

1

3

2

4

6

__________________________________________________________________________________________________________________________

Reactions at room temperature: Open vessel charged with boronic acid, olefin, Pd(OAc) 2 (0.02 equiv),

dmphen (0.024 equiv) and acetonitrile under vigorou s stirring. Reactions at elevated temperatures:

Microwave-transparent vessel charged with boronic a cid, olefin, Pd(OAc) 2 (0.02 equiv), dmphen (0.024

equiv), p-benzoquinone (1.0 equiv), acetonitrile, sealed und er air and exposed to microwave irratiation.

5

7

entry olefin product T (°C) t yield (%)

24 h10 min

8577

192 h20 min

7979

24 h10 min

7175

24 h10 min

8237

48 h10 min

9388

120 h10 min

2286

Ph

PhS

O O

rt100

N

O

Ac

O

O

Ac

O

rt100

PhS

O O

O

O

rt100

rt100

rt100

rt100

rt100

Ph

Ph

Ac

12

14

8

9

10

13

15

ααααββββ

ααααββββ

240 h10 min

8769

48 h10 min

7595

240 h10 min

596

24 h10 min

9178

120 h10 min

1538

72 h10 min

7094

72 h10 min

7094

entry olefin product T (°C) t yield (%) a__________________________________________________________________________________________________________________________

B rt100

B11 24 h10 min

6769O

O

O

O

CO2BuCO2Bu Batch Scale-Up of Oxidative Heck

O

O

O

OB(OH)2

B(OH)2

O

O

O

O

O

O

Pd(OAc) 2 (2 mol%)dmphen (2.4 mol%)

p-benzoquinone (60 mmol) MeCN, 100 °C, 20 min50 mmol 100 mmol

50 mmol 100 mmol

91%

87%

Pd(OAc) 2 (2 mol%)dmphen (2.4 mol%)

p-benzoquinone (60 mmol) MeCN, 100 °C, 20 min

+

+

• From 0.5 mmol to 50 mmol • p-Benzoquinone as palladium reoxidant• Advancer instrument• Air as reoxidant instead of O 2 or p-

benzoquinone?

dmphenNN

Lindh et al. J. Org. Chem. 2007, 7957

Batch Scale-Up of Oxidative Heck with Air as Reoxidant

O

O

O

OB(OH)2

B(OH)2

O

O

O

O

O

O

Pd(OAc) 2 (2 mol%)dmphen (2.4 mol%)

Air (4 bar), MeCN

50 mmol 100 mmol

50 mmol 100 mmol

95%

88%

100 °C, 20 min

Pd(OAc) 2 (2 mol%)dmphen (2.4 mol%)

Air (4 bar), MeCN100 °C, 20 min

+

+

• Air introduced via vessel entry port• Air as reoxidant worked fine

Lindh et al. J. Org. Chem. 2007, 7957

• A multitude of available new palladium catalysts (o r precatalysts)• Palladacycles, pincer complexes, encapsulated polyu rea polymers ......• Not much known regarding the structure of catalytic ally active species at hhigh temperature (microwave conditions) • Pd(II)/(IV) mechanism or sophisticated Pd(0) sources? Compare with old-hfashioned Pd(OAc) 2, Pd2(dba)3, Pd/C •• hEnCat 30, EnCat Pd(0)

PPd

O O

o -Tolo -Tol

O

O PPh2

PPh2

Pd OCF3

O

PdN

O

O

2

2

Modern Palladium Catalysts at High Temperature (Microwave Conditions)

Nilsson and Sjöberg et al. Submitted

Per Sjöberg

Herrmann et al J. Organomet. Chem. 1999, 23 Heck et al. J. Org. Chem. 1975, 2667

Bedford et al. New J. Chem. 2000, 745Jones et al. J. Catal. 2004, 101

• Design of experiments:• Bidentate ligand-controlled regioselective cationic Heck harylation reaction• Oxidative addition intermediates detected by ESI-MS analysis hof ongoing microwave heated reaction mixture - in ac cordance hwith Pd(0) catalysis by Pd(0) release from Pd sourc e• Internal αααα-product selectivity support Pd(0)-catalysis ( αααα/ββββ-ratio)

ArOTfAr Pd L

L OR

MW

Ar

O

Ar

OR

Pd(0)

L L

ESI-MSdetectionPd source

+ L L

H2O

ααααββββ

ORAr

+αααα

ββββ

Modern Palladium Catalysts at High Temperature (Microwave Conditions)

Nilsson and Sjöberg et al. Submitted

Catalysts as Pd(0) Sources at 150 oC

P P

P P

Ph2P PPh2

ArOTfAr Pd P

P OnBu

150 oC 1 h, MW

P PAr

OnBu

OnBuAr

Pd(0)

Ar = 1-Naphthyl

+

ααααββββ

+

αααα-product ββββ-product(120 oC)

=

PPd

O O

o-Tolo-Tol

O

O PPh2

PPh2

Pd OCF3

O

PdN

O

O

Pd(OAc) 2

2

2

Pd2(dba)3

EnCat 30EnCat Pd(0)

Yes -

Yes

Yes

Yes

Yes-

87 071 0

71 0

82 0

67 0

82 067 0

Page 5: Microwave-Accelerated Palladium- Disposition...1 Microwave-Accelerated Palladium-Catalyzed Organic and Medicinal Chemistry Mats Larhed Division of Organic Pharmaceutical Chemistry

5

Examples of ESI-MS Detected Cationic Catalytic Intermediates

P PArOTf

Ar Pd PP OnBu

150 oC 1 h, MW

Ph2P PPh2P PP

PdO O

o-Tolo-Tol

Pd

Ph2P

ArPh2P

Ph2PPPh2(II)

PPd

Ph2P PPh2(II)

Ar

OnBu

Pd

Ph2P

ArPh2P

Ph2PPPh2

O

(II)(o-Tol)2

2

+

ααααββββ

αααα-product(120 oC)

Pd(0)

= Ar = 1-Naphthyl or 4-CN-Ph

PP

Intermediates detected in an ongoing Heck reaction and verified by isotopic pattern, MS-MS and use of different ligands and aryl triflates NN Ph2P PPh2

• Pd(II)-based Palladacycles and Pincer complexes und ergo hstructural cleavage upon bidentate ligand coordinat ion hfollowed by a reduction and release of ”Pd(0)”• The bidentate ligand-controlled Heck reaction proce eds via the hidentical oxidative addition complex and deliver ex clusively thehαααα-product regardless of the Pd source• Commercially available encapsulated Pd catalysts (P d EnCat 30 hand EnCat Pd(0) show similar behavior• We conclude that it is unlikely that the investigat ed reactionshproceed via a Pd(II)/Pd(IV) redox cycle• All investigated catalysts (precatalysts) serve as useful Pd(0)hsources

Modern Palladium Catalysts at High Temperature (Microwave

Conditions)

Nilsson and Sjöberg et al. Submitted

Peter Nilsson

ON

ON+

OHN

O1) PTSA, HC(OMe)3

2)

39%

, HCl (g)

3) distillation 35%Separable on silica

• Utilizing the chiral pool

• Scope and limitation

ON

Ar-Cl

Pd( t-Bu 3P)2

O PdN

H

Ar

Cl ON

Ar

HCl (aq)O

Ar

(R)-2-Aryl-2-methyl-cyclopentanonesee?

Asymmetric Chelation-Assisted Heck Arylation with Aryl Chlorides

Nilsson et al. J. Am. Chem. Soc. 2003, 3430, Datta et al. Submitted

O PdN

H

A r

X

O

NH Ar

X

Pd

• Preferred Si-face addition furnishing R-enantiomerafter hydrolysis

• Non-preferred Re-face additionfurnishing S-enantiomerafter hydrolysis

Diastereofacial Selection

Cl

Me2N

Cl

Cl

Cl

NC Cl

91 %

94 %

Cl

OCl

O

PhCl

O

HCl

Aryl-Cl eeEntry

4 100 °C 11 h 94 %

5 100 °C 12 h

2 100 °C 18 h

1

3

59 %

60 %

91 %57 %

100 °C 9 h 68 %

6

7

100 °C 20 h 90 %55 %

100 °C 8 h 93 %69 %

100 °C 8 h 92 %67 %

100 °C 8 h 96 %60 %

100 °C 8 h 92 %65 %

8

9

Isolated YieldTemp. Time

OCl

O

HCl

Aryl-Cl eeEntry

1

140 °C 1 h

2

85 %62 %3

140 °C 1 h 89 %63 %4

Isolated YieldTemp. Time

Classical heating Microwave heating

Cl

Cl 140 °C 1 h 88 %54 %

140 °C 1.5 h 84 %50 %

Gopal et al. Submitted

O

Ar

Asymmetric Chelation-Assisted Heck Arylation with Aryl Chlorides

(R)-2-Aryl-2-methyl-cyclopentanones

0

10

20

30

40

50

60

70

80

90

100

0 4 8 12 16

∆∆∆∆∆∆∆∆G‡ (kJ/mol)

ee (%

)

0 degrees C

100 degrees C

200 degrees C

Requirements for High Selectivity

• Enantiomeric excess as a function of the difference in activation energy (∆∆(∆∆(∆∆(∆∆G‡) for an enantioselectiveprocess at different reaction temperatures

Larhed et al. Acc. Chem. Res. 2002, 717; Bremberg et al. Synthesis 2000, 1004

Page 6: Microwave-Accelerated Palladium- Disposition...1 Microwave-Accelerated Palladium-Catalyzed Organic and Medicinal Chemistry Mats Larhed Division of Organic Pharmaceutical Chemistry

6

Microwave-Accelerated Heck Spiro-Cyclizations of o-Halobenzyl

Cyclohexenyl Ethers

• Spiro[cyclohexane-1,1’-isobenzofuran] compounds• New constrained products by 5 -exo cyclization

O

XR1 R2

R1 R2OMicrowaves

[Pd]

Regioselectiveproducts

X = I, Br

Svennebring et al.

Cyclization Precursors

• Eight starting materials in good yields

HO

X

OOH

OHO

X

PTSA

Ac 2O Et3N

X = Br 92%X = I 87%

DMAP

OO

X

X = Br 83%X = I 77%

OAcO

X

X = Br 90%X = I 89%

NaBH4+

Distd MeOH /dioxane1:1

O

PTSA

HO

Xbenzene

O

X

O

XO

X = Br 85%X = I 77%

+

+MW220 °C5 minDMAc

Svennebring et al. J. Org. Chem. 2007, 5851

Heck Spiro-Cyclizations

Temp(°C)Starting material

OO

X

O

X

OHO

X

PdOAc 2

OAcO

I

I DMF

DMF

OO

O

OAcO

OO

BrBrII

Br

II

Br

II

ConditionsHeating

Solvent(%) Time

1%1%1%1%

TolueneToluene

Toluene/H 2O 19:1Toluene/H 2O 19:1

Microwave

MicrowaveClassical

Classical

180120140100

10 min18 h10 min18 h

82%71%91%82%

1%1%1%

Toluene

Toluene/H 2O 19:1Toluene/H 2O 19:1

Microwave

ClassicalMicrowave

180140100

10 min10 min18 h

51%59%58%

1% Microwave 140 10 min 54%

10%1%10%

Toluene/H 2O 19:1DMF/H2O 19:1

Microwave

MicrowaveMicrowave

180140140

10 min4 h10 min

63%54%77%

Yield Product

Svennebring et al. J. Org. Chem. 2007, 5851

HIV/AIDS Statistics 2006

• 40 million people lll infected

• 4.3 million newly infected

• 2.9 million deaths in AIDS

• 1930±±±±15 years lll transmission of SIV to lll humans

• Early 1980s AIDS

• 1983 isolation of HIV

• 1987 first antiretroviral lll therapy

• 1995 first protease lll inhibitor

Target: HIV-1 Protease

Microwave-assisted synthesis of protease inhibitors :Alterman et al. J. Med. Chem. 1999, 3835; Schaal et al. J. Med. Chem. 2001, 155;Nöteberg et al. J. Med. Chem. 2003, 734; Nöteberg et al. J. Comb. Chem. 2003, 456;Ersmark et al. J. Med. Chem. 2004, 110; Ax et al. Bioorg. Med. Chem. 2005, 755;Muthas et al. Bioorg. Med. Chem. 2005, 5371; Wannberg et al. J. Comb. Chem. 2005, 611;Ersmark et al. J. Med. Chem. 2005, 6090; Gold et al. Tetrahedron , 2006, 4671; Ekegren et al. J. Med. Chem. 2006, 1828; Wannberg et al. Bioorg. Med. Chem. 2006, 5303Reviews: Ersmark et al. Cur. Opin. Drug Discov. Dev. , 2004, 417; Wannberg et al Top. Curr. Chem. 2006. 266, 167

HIV-proteaseC2 symmetric dimer

Concerns:1) Active mutants 2) Metabolic stability3) Improved cell permeability

Brik et al. Org. Biomol. Chem. 2003, 5

HIV-1 Protease

• HIV-1 protease is an aspartic protease

• Transition-state mimics inhibit the enzyme

OH

HOO H OO

O

NH

NH

OOHOO

NNH O O

H

H

H

OO H OO

O

OHNH

NH2

(-)

P1

P1'

(-)

P1

P1'

(-)

P1

P1'

Asp 25 Asp 25' Asp 25 Asp 25' Asp 25 Asp 25'

NH

OH

O

P

P OH

NH

OH

NH

P

O

P

NH

OH

NH

O

P

P

Dihydroxyethylen Hydroxyethylamin

1

1'

1 1'

tert -Hydroxyethylamin

1'

1

Page 7: Microwave-Accelerated Palladium- Disposition...1 Microwave-Accelerated Palladium-Catalyzed Organic and Medicinal Chemistry Mats Larhed Division of Organic Pharmaceutical Chemistry

7

A New HIV-1 Protease Inhibitor C1 Core Structure

• Aim

Ekegren, J. K. Et al. J. Med. Chem . 2005, 8098

A tertiary alcohol in the transition-state mimickin g scaffold

New

NNH

OH

O

OH N

HN O

O NH

HN N

NH

O

O

OOH

N

HN O

O

N

AtazanavirK i = 2.66 nMEC50 = 0.0039 µµµµM

IndinavirK i = 0.52 nMEC50 = 0.041 µµµµM

NH

OH

O

OHN

NH

HN

R'

O

R

R''

P1

P2 P1'

P3'

P2'

A New HIV-1 Protease Inhibitor C1 Core Structure

HO

HN

R

O HN

NH

HN

R

Br O

54-76%

OH

NH

O

NNH

O HN

R

Br

46-59%

Ti(Oi-Pr)4, THF, 40 °C

HN

NH2

Br

+

EDC, NMM HOBT

EtOAc, rt

OH

OHNH

OO

(S)-isomer

Ekegren et al. Org. Biomol. Chem. 2006, 3040Wu et al. Organometallics 2006, 1434

• Shielded tertiary nalcohol by epoxidenopening l

Evaluation of the New Tertiary Alcohol C1 Transition-State Mimic

Biological results Binding mode

K i = 2.4 nM

EC50 = 1.1 µM – how to improve?

O

NH

OHOH

NNH

HN

O

Br

O

O

Br

S

CO2Me

t-Bu

Papp = 42 x 10-6 cm/s

Cl int = 266 mL/min/mg Ekegren, J. K. Et al. J. Med. Chem . 2005, 8098

Asp25 binds to backbone N instead of OH

P1′′′′ Decorations by Microwave Pd(0)-Catalyzed Cross-Coupling Reactions

• Enzyme inhibition and in vitro anti-HIV activity

• Improved Caco-2 and intrinsic clearance data

OHNH

O

NNH

HN O

O

OOH

Br

N

N

O

O

ON

4-Br 3-Br

N

N

N

N

N

S

OHNH

O

NNH

HN O

O

OOH

R''

4-R'' 3-R''

[Pd], MW

R'' =

* * * *

* only in the para series

20 - 60 min17 - 62%

OHNH

O

NNH

HN O

O

OOH

N

Ki = 5 nMEC50 = 0.18 µµµµM

Para compounds: EC50 = 0.18-1.1 µµµµM

Meta compounds: Only 2 of 9 active in cell assay

3- and 4-pyridyl in para EC50 = 0.18-0.22 µµµµM

Papp = 33 x 10 -6 cm/s

Cl int = 154 µµµµL/min/mg

Ekegren, J. K. Et al. J. Med. Chem . 2006, 1828

A New Elongated Tertiary Alcohol HIV Protease Inhibitor?

Wu, X. and Öhrngren, P. et al. J. Med. Chem . In revision

O

HN N

NH

O

O

OOH

N

HN O

O

Atazanavir8-atom spacer

NH

OH

O

OHN

NH

HN

O

R''

C1 tert- OH inhibitor6-atom spacer

O

O

NH

OH

O

OH

C3 tert- OH inhibitor8-atom spacer

NNH

HN

O

R''

O

O

• Water coordination optimized• New synthetic route needed

New C3 target scaffold

A New Elongated HIV-1 Protease Inhibitor C3 Core Structure

TBSO

NH

O

OTBSOH

HN

NH

HN

Br OO

O

TBSO

NH

O

OTBSN

NH

O HN

Br

O

O

OH

NH

O

OHN

NH

O HN

R

O

O

48%

1. Dess-Martin, 2. Na(OAc) 3BH

1. [Pd], RMR'n, MW

20 min, 120 or 130 oC

2. TBAF

14 Examples67% average yield

• P1’ optimization by lllSuzuki and Stille lll couplings

Wu, X. and Öhrngren, P. et al. J. Med. Chem . In revision

Page 8: Microwave-Accelerated Palladium- Disposition...1 Microwave-Accelerated Palladium-Catalyzed Organic and Medicinal Chemistry Mats Larhed Division of Organic Pharmaceutical Chemistry

8

Antiviral Activity and X-Ray Binding Mode

12d

OH

NH

O

OHN

NH

OR

HN O

O

• Improved water binding lll but tert -OH binds only lll to one aspartate residue

R-group K i nM

EC50

µµµµM CC50 (µµµµM)

Ph 5.7 1.20 >10 4-F-Ph 6.7 0.98 >10 4-Cl-Ph 3.4 0.91 >10 4-Br-Ph 3.3 0.85 >10 4-CN-Ph 2.9 1.20 >10 4-NMe2-Ph 4.9 0.98 >10 CH(CH3)2 6.8 1.80 >10

N 2.8 0.47 >10

N

N

2.4 0.22 >10 ON 3.6 0.50 >10

N

O 11 0.88 >10

N N

3.3 0.17 >10 N

O

N 3.6 0.19 >10

N

S 2.3 0.21 >10 N

S 3.5 0.51 >10 N

S 24 1.00 >10

N

N

S 2.3 0.48 >10

O S

N

Cl 5.5 0.60 >10

4-I-Ph 4.5 0.82 >10

7.3 0.78 7.5

N 3.6 0.19 >10 N 2.8 0.17 >10

S 10 0.56 >10

Acknowledgement

– Prof. Anders Hallberg

– Prof. Bertil Samuelsson

– Prof. Åke Pilotti

– Prof. Anders Karlén

– Prof. Torsten Unge

– Prof. Kristina Moberg

– Dr. Per Sjöberg

– Dr. Anja Sandström

– Dr. Xiongyu Wu

– Dr. Murugaiah Andappan

– Dr. Peter Nilsson

– Dr. Luke Odell

– Dr Ulf Bremberg

– Dr. Prasad Appakuttan

– Dr Robert Rönn

– Dr. Jenny Ekegren

– Dr. Stefanie Schlummer

– Dr. Johan Wannberg

– Dr. Andreas Svennebring

– Dr. Per-Anders Enquist

– Gopal Datta

– Per Öhrngren

– Jonas Lindh

Acknowledgement

• Swedish Foundation for Strategic Research• The Swedish Research Council• Knut och Alice Wallenbergs Foundation• Medivir AB

Division of Organic Pharmaceutical Chemistryat Uppsala University

Reactive Intermediates

UniqueIsotopicPattern

CationicPathway

On-LineMonitoring

ESI-MS

Pd

m/z112110108106104102100

norm

alis

ed in

tens

ity

Mechanistic Investigation of the Oxidative Heck Reaction

O2

H 2O2

C σσσσ

Pd(II)N

N

Pd(II)N

Ar N

Pd(II)N

Ar N

R

R

ArPd(II)

N

NR

Ar Pd(II)H

N

NR

Ar

Ar B(OH )2

D

E

RB

III

II

I

IV

V

VIA

C ππππ

Pd(II)H N

N

O2

H 2O2

C σσσσ

Pd(II)

N

N

Pd(II)

N

Ar N

Pd(II)

N

Ar N

R

R

ArPd(II)

N

NR

Ar Pd(II)H

N

NR

Ar

Ar B(OH )2

D

E

RB

III

II

I

IV

V

VIA

C ππππ

Pd(II)H N

N

N N

Electrospray Ionization Mass Spectrometry ESI-MS

• A mass spectrometer needs the sample to be gaseous. The ESI technique solves this problem without heat.

Page 9: Microwave-Accelerated Palladium- Disposition...1 Microwave-Accelerated Palladium-Catalyzed Organic and Medicinal Chemistry Mats Larhed Division of Organic Pharmaceutical Chemistry

9

MS Spectrum ( m/z = 100-800)

MS spectrum for the standard reaction

100 200 300 400 500 600 700 800

m/z

Inte

nsity

A3

A2

A1

B1

B2

C1F1

B3

2a+Na+

2a+MeCN+Na+

4a+Na+

2[4a]+Na+

3[4a]+Na+

4a+2a+Na+

4a+MeCN+Na+

2MeCN+Na+

Pd OAcN

N

NN

N

N

Pd OAc

Pd OAcN

N

N

N

N

N

Pd

PdN

N

N

entry m/z-ratio Pd(II)-complex

A1

A2

A3

B1

B2

373

455

581

405

446

1

2

3

4

5

Structural Proposition of Observed Complexes

N

OPd

N

N

PdN

N

NN

NO

Pd

N

N

PdN

NNH

or C1

D1

B3613

516

538

6

7

8

entry m/z-ratio Pd(II)-complex

Single Charged Cationic Palladium(II) Complexes Detected in the Standard Oxidative Heck Reaction with Using ESI-MS-(+) AnalysisEnquist et al. J. Org. Chem. 2006, 8779

MS Spectrum ( m/z 440-454)

MS spectrum of Pd complex B2 (C23H22N3Pd, m/z 446) solid line, and theoretical isotopic pattern dotted line

B2

0

20

40

60

80

100

440 442 444 446 448 450 452 454

m/z

Nor

mal

ized

Inte

nsity

(%

)

B2

0

20

40

60

80

100

440 442 444 446 448 450 452 454

m/z

Nor

mal

ized

Inte

nsity

(%

)

PdN

N

N

B2

• MS-MS spectrum of Pd complex B2 ( m/z 446)

MS-MS (Tandem Mass)

0 50 100 150 200 250 300 350 400 450

m/z

Inte

nsi

ty

B2405

313

224

207

PdN

N

N

B2m/z 446

- MeCN- Pd

- Toluene

Chemical Verification and Conclusion

R

B(OH)2

N

OPd(OAc) 2, ligand

R=MeR=n -Bu

N N N N

Ph Ph

N

O

R

+NaOAc, solvent air, rt

( )nn=1n=3

( )n

Solvent: MeCN or EtCN Ligand:

• Exchange of reaction components to chemically equivalent componentswith different mass provides the expected m/z ratios

• In conclusion– Three different types of observed palladium interme diates:

(A) Starting intermediates, (B) Transmetallation int ermediates, (C) Insertion intermediate

• The suggested catalytic cycle seems to be correctEnquist et al. J. Org. Chem. 2006, 8779